52 articles
John W. Eikelboom
John W. Eikelboom is an Australian-trained hematologist and thrombosis researcher who is Professor of Medicine at McMaster University in Hamilton, Ontario, and led the COMPASS trial.
Kenneth A. Bauer
Kenneth A. Bauer is an American hematologist and Professor of Medicine at Harvard Medical School, based at Beth Israel Deaconess Medical Center in Boston, known for research on hypercoagulable states.
Kenneth Brinkhous
Kenneth Brinkhous (1908–2000) was an American pathologist who discovered that hemophilia results from a missing clotting factor, Factor VIII, and pioneered plasma replacement therapy for it.
Kunihiro Hattori
Kunihiro Hattori (服部邦洋) is a Japanese antibody engineer who conceived and led creation of emicizumab, the first bispecific antibody therapeutic for hemophilia A, earning the 2026 Lasker–DeBakey award.
Marc Carrier
Marc Carrier is a Canadian hematologist at The Ottawa Hospital and University of Ottawa known for the AVERT and SOME trials on blood clots and cancer screening.
Margareta Blombäck
Margareta Blombäck (1925–2024) was a Swedish physician and hematologist, a pioneer of hemostasis research who led the Karolinska Hospital coagulation laboratory and held its coagulation research chair.
Mark Crowther
Mark A. Crowther is a Canadian hematologist and thrombosis physician-scientist at McMaster University in Hamilton, Ontario, known for clinical trials of anticoagulant reversal agents, including andexanet alfa.
Mary Cushman
Mary Cushman is an American hematologist and cardiovascular epidemiologist at the University of Vermont, known for Women's Health Initiative findings on hormone therapy and for co-leading the REGARDS stroke study.
Menno V. Huisman
Menno V. Huisman, born 1956, is a Dutch internist and professor emeritus at Leiden University Medical Center, known for the YEARS algorithm and Hestia rule for pulmonary embolism.
Paul M. Aggeler
Paul M. Aggeler (1911–1969) was an American hematologist and professor of medicine at UCSF who discovered Factor IX deficiency, now called hemophilia B, and first described hereditary warfarin resistance.
Phin Cohen
Phin Cohen is an American physician and hematologist at Harvard Medical School and the Peter Bent Brigham Hospital in Boston, known for 1960s research on platelets and thrombocytopenia.
Robert W. Colman
Robert W. Colman is an American hematologist and physician-scientist at Temple University School of Medicine in Philadelphia, known for defining the plasma kallikrein-kinin contact activation system.
Russell D. Hull
Russell D. Hull is a Professor of Medicine at the University of Calgary who directs its Thrombosis Research Unit; his New England Journal trials shortened heparin treatment and established low-molecular-weight heparin.
Russell F. Doolittle
Russell F. Doolittle (1931–2019) was an American biochemist at the University of California, San Diego who explained how fibrin polymerizes to clot blood and built phylogenetic trees from protein sequences.
Samuel Z. Goldhaber
Samuel Z. Goldhaber is an American cardiologist who directs the Thrombosis Research Group at Brigham and Women's Hospital and is a Harvard Medical School professor.
Shannon M. Bates
Shannon M. Bates, also known as Shannon Bates, is a Canadian hematologist at McMaster University known for research on venous thromboembolism, especially thrombosis in women.
Suzanne C. Cannegieter
Suzanne C. Cannegieter is a Dutch clinical epidemiologist and professor at Leiden University Medical Center, known for a landmark 1995 study of anticoagulation in mechanical heart valve patients.
Tage Astrup
Tage Astrup (1908–November 2006) was a Danish biochemist who pioneered fibrinolysis research and proposed the haemostatic balance, the equilibrium between blood clotting and clot dissolution.
Takehisa Kitazawa
Takehisa Kitazawa (北沢久寿), born 1968, is a Japanese antibody researcher at Chugai Pharmaceutical who co-invented emicizumab (Hemlibra) for hemophilia A and shared the 2026 Lasker–DeBakey Award.
Tiziano Barbui
Tiziano Barbui, born in 1938, is an Italian hematologist at Bergamo who led the ECLAP trial of low-dose aspirin in polycythemia vera and won the 2013 Jean Bernard award.
William C. Aird
William C. Aird is a hematologist and Professor of Medicine at Harvard Medical School who practices at Beth Israel Deaconess Medical Center in Boston and studies endothelial heterogeneity.
William Geerts
William Geerts is a Canadian physician-scientist and professor of medicine at the University of Toronto whose research defined how hospitals prevent venous thromboembolism after major trauma.